Clinical Trials List
2020-01-21 - 2024-04-08
Phase III
Recruiting3
ICD-10C11.0
Malignant neoplasm of superior wall of nasopharynx
ICD-10Z51.12
Encounter for antineoplastic immunotherapy
ICD-9147.0
Malignant neoplasm of superior wall of nasopharynx
-
Trial Applicant
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2026/04/01
Investigators and Locations
The Actual Total Number of Participants Enrolled
0 Recruiting
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- Kwang-Yu Chang Division of Hematology & Oncology
- Shang-Yin Wu Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Recruiting
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
9 participants
-
Global
263 participants
